Chemokine Receptors in Epithelial Ovarian Cancer
AbstractOvarian carcinoma is the deadliest gynecologic malignancy with very poor rate of survival, and it is characterized by the presence of vast incurable peritoneal metastasis. Studies of the role of chemokine receptors, a family of proteins belonging to the group of G protein-coupled receptors, in ovarian carcinoma strongly placed this family of membrane receptors as major regulators of progression of this malignancy. In this review, we will discuss the roles that chemokine-receptor interactions play to support angiogenesis, cell proliferation, migration, adhesion, invasion, metastasis, and immune evasion in progression of ovarian carcinoma. Data regarding the role that the chemokine receptors play in the disease progression accumulated insofar strongly suggest that this family of proteins could be good therapeutic targets against ovarian carcinoma. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Muralidhar, G.G.; Barbolina, M.V. Chemokine Receptors in Epithelial Ovarian Cancer. Int. J. Mol. Sci. 2014, 15, 361-376.
Muralidhar GG, Barbolina MV. Chemokine Receptors in Epithelial Ovarian Cancer. International Journal of Molecular Sciences. 2014; 15(1):361-376.Chicago/Turabian Style
Muralidhar, Goda G.; Barbolina, Maria V. 2014. "Chemokine Receptors in Epithelial Ovarian Cancer." Int. J. Mol. Sci. 15, no. 1: 361-376.